257 results
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
16 May 24
Lifecore Biomedical Completes Incremental Liquidity Initiatives
4:48pm
.
Subsidiary Assignment for the Benefit of Creditors
On May 15, 2024, the Company entered into an assignment for the benefits of creditors related
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
in the Collateral; (iv) salaries, wages and benefits due to employees of any Loan Party (including amounts for employee wage claims for earned wages, vacation pay … benefits of the Loan Documents. (B) The Administrative Agent may, in its discretion (but shall have absolutely no obligation to), require Lenders to honor
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
Amounts and Separation Benefits. Executive’s employment with Lifecore Biomedical, Inc. (the “Company”) will end effective __________, 2024 … ”), the Company shall provide Executive with the separation benefits described in Sections 1(a) through (d) below (collectively, the “Separation Benefits
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
compensation and benefits. It is not intended to be a comprehensive description of all benefits available to you or to provide the details of the plans … that govern the administration of compensation, and benefits, as our offerings change periodically. Your compensation and benefits will be established
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
compensation, and in no way represents any portion of a Participant’s salary, compensation, or other remuneration for purposes of pension benefits
8-K
n0e5g1ynhd t9qmpnddw
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.3
6futqesw59kt4b6u
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
6e0qlup
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.2
z4z0icbjnylqhl4i33
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-99.1
gjxrxuah4akfy1 80
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
q7lnw
2 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
48i p6dsm33
6 Apr 23
Regulation FD Disclosure
4:10pm
8-K
EX-10.1
9jjhfbgjft7y9dw 1cfb
25 Nov 22
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-99.1
gtodkyzsj iq965e
16 Nov 22
Lifecore Biomedical Announces Completion of Corporate Name Change
4:47pm